Abstract

BackgroundAbnormal expression of SOCS3 has been implicated in myeloproliferative neoplasms, but the role of SOCS3 in the pathogenesis of leukemia remains largely unknown. Here, we examined the function of SOCS3 in the growth and chemo-sensitivity of chronic myeloid leukemia (CML) and explored the involved mechanisms.MethodsExpression levels of SOCS3 in several leukemia cell lines and bone marrow mononuclear cells (BMNCs) from CML patients were determined using quantitative real-time PCR (qPCR) and Western blotting (WB). The roles of SOCS3 in the proliferation, apoptosis, and drug resistance of CML cells were examined by clonogenic progenitor cell assay, flow cytometry, and CCK-8 assay. A detailed analysis of the underlying mechanism of SOCS3 in K562 cells was performed using the Human HT-12 v4 Expression BeadChip, which has more than 48000 gene probes including 600 microRNAs (miRNA) probes. The correlation between the mRNA expression of SOCS3 and miR-124-3p in BMNCs from 30 CML patients was tested by qPCR and analyzed by Pearson correlation and linear regression analysis. The potential target of miR-124-3p in CML cells was explored using the luciferase reporter assay, qPCR, and WB. The effect of SOCS3 on the miR-124-3p/B4GALT1 axis was investigated by qPCR, WB, CCK-8 assay, and tumorigenicity assays in nude mice.ResultsSOCS3 was down-regulated in CML cell lines and most of BMNCs from CML patients, and the expression level of SOCS3 was associated with the inhibition of cell proliferation and drug resistance of CML cells. Over-expression of SOCS3 in K562 cells inhibited the expression of leukemia-specific genes and promoted the expression of some miRNAs, among which miR-124-3p was the highest. SOCS3 over-expression enhanced the expression of miR-124-3p and vice versa. The mRNA expression of miR-124-3p and SOCS3 in BMNCs from 30 CML patients was positively correlated. Consistently, the tumor suppressing effects of SOCS3 were partially neutralized by the miR-124-3p inhibitor. B4GALT1 was downstream of miR-124-3p and regulated by SOCS3/miR-124-3p in vitro. Furthermore, SOCS3 over-expression could inhibit the growth and B4GALT expression of K562 cells in vivo.ConclusionsSOCS3/miR-124-3p/B4GALT1 axis plays an important role in the pathogenesis of CML.Electronic supplementary materialThe online version of this article (doi:10.1186/s13045-016-0300-3) contains supplementary material, which is available to authorized users.

Highlights

  • Abnormal expression of suppressor of cytokine signaling 3 (SOCS3) has been implicated in myeloproliferative neoplasms, but the role of SOCS3 in the pathogenesis of leukemia remains largely unknown

  • SOCS3 contributed to imatinib-induced apoptosis of chronic myeloid leukemia (CML) cells We examined SOCS3 expression levels in K562 and KU812 cells prior to and after imatinib treatment. quantitative real-time PCR (qPCR) assays demonstrated a marked increase in mRNA levels of SOCS3 after imatinib treatment in two CML cell lines

  • The results showed that SOCS3 over-expression enhanced the expression of miR-124-3p, and that SOCS3 knock-down inhibited the expression of miR124-3p in both cell lines (Fig. 5 a, b)

Read more

Summary

Introduction

Abnormal expression of SOCS3 has been implicated in myeloproliferative neoplasms, but the role of SOCS3 in the pathogenesis of leukemia remains largely unknown. We examined the function of SOCS3 in the growth and chemo-sensitivity of chronic myeloid leukemia (CML) and explored the involved mechanisms. SOCS3−/− mice die in utero because of fetal liver erythrocytosis, and over-expression of SOCS3 blocks fetal liver erythrocytosis, implying that SOCS3 plays a critical role in the negative regulation of hematopoiesis [8, 9]. Evidence suggests a potential role of SOCS3 in the pathogenesis of leukemia. Al-Jamal et al reported that down-regulation of SOCS3 was involved in the resistance of CML cells to imatinib [11]. A better understanding of the function and underlying molecular mechanisms of SOCS3 will contribute to the precision medicine in the field of CML

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call